Dr. Graeme S Steele , MD
Urology • Boston, MA
45 Francis Street, Asbii-3, Brigham And Womens Hospital Division Of Urology
Boston, MA 02115
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 12, 2006; this date does not establish years in practice.
-
Published CMS data list 3,023 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 690 service units.
- 51798 — Ultrasound measurement of bladder capacity after voiding: 579 service units.
- 52000 — Diagnostic exam of bladder and urethra using an endoscope: 378 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 30 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,576 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 603 prescription fills, including refills.
- Finasteride — 325 prescription fills, including refills.
- Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) — 97 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Urology in Boston, MA (2024, 58 clinicians with data). Median for this group: 619. Middle half: 403 to 1,208.
More Medicare Part B services than 65% of clinicians listed under Urology in Massachusetts (2024, 225 clinicians with data). Median for this group: 1,515. Middle half: 592 to 4,241.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,899 in 2020 to 3,023 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
45 Francis Street, Asbii-3
Brigham And Womens Hospital Division Of Urology
Boston, MA 02115
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Brigham And Womens Physicians Organization Inc; Dana-Farber Cancer Institute, Inc.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1981
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,407 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $435,613 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $329,164 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,756 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$94,996 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $35.06 in 2025
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2025.
Years since graduation
45 years (graduated 1981)
CMS Doctors and Clinicians data list 1981 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Steele has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Steele as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Boston and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Urology in Boston, MA (2024, 58 clinicians with data). Median for this group: 619. Middle half: 403 to 1,208.
More Medicare Part B services than 65% of clinicians listed under Urology in Massachusetts (2024, 225 clinicians with data). Median for this group: 1,515. Middle half: 592 to 4,241.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Boston, MA (2024, 58 clinicians with data). Median for this group: $78,529. Middle half: $38,489 to $139,956.
A higher Medicare-allowed amount than 90% of clinicians listed under Urology in Massachusetts (2024, 225 clinicians with data). Median for this group: $140,662. Middle half: $71,905 to $260,318.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Boston, MA (2024, 58 clinicians with data). Median for this group: $60,066. Middle half: $27,926 to $103,868.
A higher Medicare payment amount than 90% of clinicians listed under Urology in Massachusetts (2024, 225 clinicians with data). Median for this group: $101,776. Middle half: $53,181 to $198,312.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Urology in Boston, MA (2024, 69 clinicians with data). Median for this group: 337. Middle half: 79 to 773.
More Part D prescriptions than 70% of clinicians listed under Urology in Massachusetts (2024, 248 clinicians with data). Median for this group: 884. Middle half: 317 to 1,783.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Urology in Boston, MA (2024, 69 clinicians with data). Median for this group: $22,329. Middle half: $1,167 to $82,582.
Close to the middle for clinicians listed under Urology in Massachusetts (2024, 248 clinicians with data). Median for this group: $77,647. Middle half: $20,229 to $203,477.
114 active clinicians are listed under Urology with a practice address in Boston, MA (377 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Boston
50% of these 114 clinicians have the CMS telehealth indicator.
60.5% of these 114 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 2,899 in 2020 and 3,023 in 2024.
- 2020: 2,899
- 2021: 3,321
- 2022: 3,215
- 2023: 3,040
- 2024: 3,023
-
Medicare-allowed amount
Medicare-allowed amount increased 15% from $379,472 in 2020 to $435,613 in 2024.
- 2020: $379,472
- 2021: $485,920
- 2022: $413,665
- 2023: $382,988
- 2024: $435,613
-
Paid by Medicare
Paid by Medicare increased 16% from $283,878 in 2020 to $329,164 in 2024.
- 2020: $283,878
- 2021: $367,277
- 2022: $312,037
- 2023: $289,699
- 2024: $329,164
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 35% from 1,169 in 2020 to 1,576 in 2024.
- 2020: 1,169
- 2021: 1,663
- 2022: 1,532
- 2023: 1,535
- 2024: 1,576
-
30-day fills
30-day fills increased 55% from 2,423 in 2020 to 3,756 in 2024.
- 2020: 2,423
- 2021: 3,485
- 2022: 3,364
- 2023: 3,401
- 2024: 3,756
-
Part D drug cost
Part D drug cost increased 55% from $61,290 in 2020 to $94,996 in 2024.
- 2020: $61,290
- 2021: $129,817
- 2022: $147,929
- 2023: $140,288
- 2024: $94,996
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $89.99 in 2019 to $35.06 in 2025.
- 2019: $89.99
- 2020: $31.85
- 2021: $11.19
- 2022: $217.30
- 2025: $35.06
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $35.06.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Education
In-kind items and services
|
IMFINZI | General | $35.06 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
690 | 629 | $394.69 | $98.01 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
579 | 549 | $164.10 | $13.13 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
378 | 334 | $1095.23 | $267.99 |
|
51741
Electronic assessment of bladder emptying
|
253 | 233 | $430.00 | $13.68 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
203 | 203 | $509.52 | $120.23 |
|
99443
Telephone medical discussion with physician, 21-30 minutes
|
167 | 153 | $553.51 | $138.69 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
149 | 134 | $553.97 | $136.88 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
116 | 78 | $97.39 | $25.08 |
|
52281
Dilation of urethra using an endoscope
|
49 | 34 | $2312.84 | $357.36 |
|
52287
Exam with injections of chemical for destruction of bladder using an endoscope
|
39 | 28 | $819.00 | $161.69 |
|
51728
Complex measurement of pressure of urine flow in bladder with voiding pressure studies
|
35 | 35 | $1679.89 | $410.43 |
|
51797
Insertion of device into abdomen with pressure and urine flow rate study
|
34 | 34 | $1012.88 | $215.01 |
|
52235
Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm
|
32 | 26 | $2366.00 | $296.77 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
31 | 22 | $97.81 | $25.20 |
|
52332
Insertion of stent in ureter using an endoscope
|
27 | 15 | $2082.96 | $170.54 |
|
52005
Insertion of tube into ureter using an endoscope through bladder area
|
26 | 26 | $817.00 | $130.82 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
24 | 24 | $745.00 | $139.39 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
22 | 22 | $520.00 | $85.82 |
|
55845
Removal of prostate gland and surrounding lymph nodes on both sides of pelvis through abdominal incision
|
20 | 20 | $5675.60 | $1380.55 |
|
50590
Shock wave crushing of kidney stones
|
18 | 15 | $2780.00 | $604.85 |
|
49905
Repair of abdomen using abdominal lining graft
|
16 | 16 | $1709.00 | $360.84 |
|
99442
Telephone medical discussion with physician, 11-20 minutes
|
15 | 15 | $393.40 | $98.39 |
|
51595
Removal of bladder and lymph nodes on both sides of pelvis with transplantation of ureters to small or large bowel with creation of urinary opening
|
14 | 14 | $10188.32 | $2295.84 |
|
52234
Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm
|
14 | 14 | $1686.00 | $252.24 |
|
53445
Insertion of inflatable urethra or bladder neck sphincter
|
14 | 14 | $4813.00 | $801.90 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 603 | 51,886 | $10,248.48 | 181 |
| Finasteride | Finasteride | 325 | 28,431 | $5,032.84 | 104 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 97 | 825 | $192.83 | 67 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 77 | 5,415 | $2,744.28 | 23 |
| Myrbetriq | Mirabegron | 68 | 4,410 | $65,574.65 | 24 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 51 | 480 | $416.10 | 35 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 139 | $141.55 | 33 |
| Methenamine Hippurate | Methenamine Hippurate | 35 | 1,957 | $1,925.35 | — |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 35 | 2,834 | $1,085.35 | — |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 32 | 2,202 | $602.57 | 13 |
| Levofloxacin | Levofloxacin | 28 | 144 | $101.45 | 16 |
| Terazosin Hcl | Terazosin Hcl | 24 | 1,500 | $357.70 | — |
| Testosterone Cypionate | Testosterone Cypionate | 23 | 644 | $315.57 | — |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | 1,260 | $550.58 | — |
| Dutasteride | Dutasteride | 19 | 1,596 | $988.90 | — |
| Testosterone | Testosterone | 18 | 630 | $2,140.83 | — |
| Sildenafil Citrate | Sildenafil Citrate | 18 | 540 | $186.67 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 90 | $91.84 | 14 |
| Gavilyte-G | Peg3350/Sod Sulf,bicarb,cl/Kcl | 17 | 18 | $245.32 | 17 |
| Tadalafil | Tadalafil | 15 | 630 | $132.32 | — |
| Estradiol | Estradiol | 13 | 763 | $1,920.34 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20050103000204
MA
0345208716
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Dana-Farber Cancer Institute, Inc.
450 Brookline Ave, Boston, MA 022155418
Phone: 6176323586
Brigham And Womens Physicians Organization Inc
45 Francis St, Boston, MA 021156105
Phone: 6177325500
Dana-Farber Cancer Institute, Inc.
450 Brookline Ave, Boston, MA 022155450
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Physician Assistant (Certified)
Physician Assistant
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated May 12, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Boston
- Dr. Robert Wang, MD
- Dr. Avinash Maganty, MD
- Dr. Bartley Cilento, MD
- Dr. Alexander Cole, MD
- Dr. Ajay Nehra, MD
- Dr. Keyan Salari, MD, PhD
Mailing Address
111 Cypress St
Brookline, MA 024456002
Phone: 8573070896